Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02340650 · ClinicalTrials.gov registry record

High Resolution Imaging for Early and Better Detection of Bladder Cancer

A clinical trial, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
37
Enrollment target

NCT02340650: Completed study, sponsored by The University of Texas Health Science Center, Houston.

NCT02340650 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 37 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02340650 has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
37 participants
Enrollment target

Study Summary

The goal of this study is to develop, optimize, and validate a High Resolution Imaging System in the bladder that displays images in real-time, providing automated diagnostic criteria for bladder cancer screening. High resolution images of normal bladder tissue and suspicious bladder lesions will be collected from patients who present to the study site for clinical evaluation.

Interventions

  • DEVICE Standard High Resolution Microendoscope and/or Line-Scanning Confocal High Resolution Microendoscope

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2015-04
Est. Completion 2020-09-30

What the finished NCT02340650 record still lists

NCT02340650 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 37 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Standard High Resolution Microendoscope and/or Line-Scanning Confocal High Resolution Microendoscope is the first listed.

NCT02340650 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02340650 about?

NCT02340650 is a clinical study titled "High Resolution Imaging for Early and Better Detection of Bladder Cancer". The goal of this study is to develop, optimize, and validate a High Resolution Imaging System in the bladder that displays images in real-time, providing automated diagnostic criteria for bladder cancer screening. High resolution images of normal bladder tissue and suspicious bladder lesions will be...

What is the current status of trial NCT02340650?

This trial is currently completed. The enrollment target is 37 participants. The study started on 2015-04. Estimated completion is 2020-09-30.

What interventions are being tested in trial NCT02340650?

The interventions under investigation include: Standard High Resolution Microendoscope and/or Line-Scanning Confocal High Resolution Microendoscope (DEVICE).

Who is sponsoring clinical trial NCT02340650?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02800486 · 37 participants · Phase 2

    Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

  • NCT03173937 · 37 participants · Phase 1

    Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome

  • NCT03295227 · 37 participants · Phase 1

    Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer

  • NCT03401047 · 37 participants · Early Phase 1

    Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02340650, the US trial registry maintained by the National Library of Medicine. NCT02340650 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.